The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
HER2 status as an independent prognostic marker in patients with advanced gastric cancer receiving adjuvant chemotherapy after curative gastrectomy.
Y. S. Park
No relevant relationships to disclose
M. Ryu
No relevant relationships to disclose
H. J. Park
No relevant relationships to disclose
H. J. Kim
No relevant relationships to disclose
B. Ryoo
No relevant relationships to disclose
J. H. Yook
No relevant relationships to disclose
B. S. Kim
No relevant relationships to disclose
S. J. Jang
No relevant relationships to disclose
Y. Kang
No relevant relationships to disclose